Availability of anticancer biosimilars in 40 countries.
作者信息
Huang Hui-Yao, Wu Da-Wei, Ma Fei, Liu Zhi-Lei, Shi Ju-Fang, Chen Xia, Wang Shu-Hang, Fang Hong, Bai Ying, Yu Yue, Fang Yuan, Sun Chao, Fan Qi, Wu Ying, Fan Rui-Hua, Zhou Cai-Yun, He Bao-Xia, Dai Min, Li Ning, Xu Bing-He, Sun Yan, He Jie
机构信息
Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
出版信息
Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5.
Abstract
摘要
Zotero 插件